Skip to main content

Research Team | Dr. Nangia

A_NangiaAjay Nangia, MBBS

Dr. Nangia is actively involved with research in male contraception, testicular cancer awareness, as well as the past study of vitamin D in sperm/testicular physiology. He has been very involved in access to care research for male infertility, as well as research with the CDC on contraception, male reproduction advocacy and testosterone use in the reproductive years. He has published and researched in laboratory testing for male reproduction. 

He is Co-Principal Investigator on cutting edge research and development of a reversible male contraceptive through the Male Contraceptive Trials Network with UCLA and University of Washington. He is also involved with ongoing research in the development of a non-hormonal reversible male contraception (H2-gamendazole) that is very promising and may go into clinical trials in the next few years. This research has been under the guidance of Dr. Joseph Tash from the Department of Molecular and Integrative Physiology.

Last modified: Sep 28, 2018